|4Jan 4, 5:11 PM ET

GILL JOHN 4

4 · Altimmune, Inc. · Filed Jan 4, 2019

Insider Transaction Report

Form 4
Period: 2019-01-02
GILL JOHN
Director
Transactions
  • Award

    Stock Options (option to buy)

    2019-01-02+20,00020,000 total
    Exercise: $2.60Exp: 2029-01-02Common Stock, par value $0.0001 (20,000 underlying)
Footnotes (1)
  • [F1]The option becomes vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT